About this trial
The goal of this clinical trial is to: (1) implement and test the feasibility of a new VR-ODT intervention offered as part of usual therapy time of patients with a sub-acute stoke; (2) explore the acceptability of the intervention from the perspective of clinicians and patients and; (3) implement measures to optimize the uptake and sustainability of the intervention within the clinical setting.
Participants will engage in a personalized VR-ODT training for 4 weeks (2X 1hr/week) targeting six well-established community walking demands related to (1) walking speed and (2) distance; (3) postural transitions; (4) obstacle avoidance; (5) dual-task walking and; (6) a combination of demands 1-5. For each demand, patients will progress through levels of increasing difficulty according to personalized goals and success criteria.
Eligibility criteria
Qualifiers
be aged between 40 and 74 years;
have normal/corrected visual and auditory acuity present;
present a first-ever supratentorial unilateral stroke of 1-24 weeks duration;
present the ability to walk independently with/without walking aids for at least 1 min at a speed of 0.4-0.9 m/s;
Disqualifiers
Subjects with comorbidities interfering with walking
Subjects with comorbidities interfering with visual perception
Subjects without medical clearance for exercise
Trial design
Treatments tested in this trial
- Virtual Reality Training
Treatment groups
Sponsors and collaborators
McGill University
Lead sponsor
Jewish Rehabilitation Hospital
Collaborator